After FDA rejection, Gilead's long-acting HIV med Sunlenca snags first global nod Anthony Fauci, the face of the White House's COVID-19 response, is stepping down from public service in December The top 10 global R&D institutes of 2021 Elon Musk reportedly approached Neuralink competitor Synchron about potential deal: Reuters Employer health costs set to rise 6.5% in 2023: Aon Insulet's Omnipod 5 insulin pump scores FDA nod for toddlers with Type 1 diabetes 2 biotechs swoop into monkeypox scene with new R&D licensing pact Takeda's dengue fever vaccine picks up first global nod in Indonesia Signify Health shares jump as Amazon, UnitedHealth reportedly among bidders for takeover deal Novo Nordisk to explore obesity risk tests with Digbi Health pilot project Thermo Fisher kicks off production at giant plant in Tennessee, where it plans to hire more than 1,000 Ex-Takeda leader to provide steady hand as Tessa's CEO after C-suite churn Teleflex snaps up surgical stapler maker Standard Bariatrics for $170M upfront Biden admin releases final surprise billing rule that updates dispute resolution process after legal setbacks Featured Story | By Angus Liu Nearly six months after an FDA rejection, Gilead Sciences’ next-generation, long-acting HIV med lenacapavir has picked up its global-first approval in Europe. But the company still needs to find the first-in-class drug a proper combination partner after a high-profile Merck setback. read more |
| |
|---|
|
Top Stories By Dave Muoio The country's foremost infectious disease expert's career has included over 50 years at the National Institutes of Health, including 38 years as director of the National Institute of Allergy and Infectious Diseases. He advised seven presidents' responses to pressing infectious disease threats but became a household name during the COVID-19 pandemic. read more By Max Bayer Advances in the biomedical industry are often a function of quality research produced at academic research institutions around the world. This year's list of top R&D outposts had a number of changes, namely the addition of more Chinese institutions. read more By Andrea Park If you can’t beat ‘em, join ‘em. Brain-computer interface developer Synchron has already begun implanting its own devices in a clinical trial, steps ahead of Elon Musk's Neuralink. read more By Paige Minemyer This is more than double the 3% increase that employers saw in 2022 but far below the current inflation index, according to Aon. read more By Andrea Park Just a few weeks into the full-scale rollout of its Omnipod 5 insulin pump, Insulet has gotten the green light to expand the device’s reach even further. read more By Gabrielle Masson Lytic Solutions has circled in on NightHawk Biosciences’ monkeypox vaccine science, penning a licensing deal with the ultimate goal of developing a vaccine that will address a potential monkeypox pandemic. read more By Zoey Becker After a long road, Takeda's dengue fever vaccine has finally picked up its first global approval in Indonesia, where the dengue fever epidemic runs rampant. The approval was based on results of Takeda's phase 3 efficacy study, dubbed TIDES. read more By Heather Landi Signify Health shares jumped nearly 40% premarket Monday morning as reports surfaced that Amazon and UnitedHealth Group are both eyeing a bid for the home health technology and services provider. read more By Conor Hale By working with Digbi and the startup’s digital screening offerings, the pilot will explore how a person’s genes, proteins, gut bacteria and lifestyle data can help predict whether they may have a high or low risk of obesity. read more By Kevin Dunleavy As part of its recent expansion surge, Thermo Fisher has identified single-use technology (SUT) manufacturing as an important area of focus. On Monday, when the Massachusetts-based manufacturer opened a $105 million plant in Lebanon, Tennessee, it became the company’s largest SUT site in its growing network. read more By Gabrielle Masson Former Takeda exec Thomas Willemsen will be taking the reins as Tessa Therapeutic’s new president and CEO as the CAR-T biotech gears up in anticipation of several clinical milestones. read more By Conor Hale Standard Bariatrics’ Titan SGS system, which received an FDA clearance last year, is designed for use in weight loss procedures and can deliver a long, continuous line of staples in a single firing. read more By Heather Landi The Biden administration released Friday a final rule that updates the arbitration process providers and insurers can use to settle out-of-network billing disputes after the federal government suffered several legal setbacks to the No Surprises Act. read more Resources Sponsored by: Ferma.AI, a Product of ZoomRx Improve your congress competitive intelligence and cut down costs by 50% Sponsored by: Catalent Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Bio-Techne Advanced research requires advanced tools. Our next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Simply load, scan, and insert your cartridge and come back to fully analyzed results in 75 minutes. Rethink your ELISA, with Ella. Sponsored by: Thermo Fisher Scientific Set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Triangle Insights Group, LLC The TrialCard/Triangle Insights Group platform is uniquely positioned to support you as your asset progresses through the value chain, by integrating strategic commercialization and market access insights with comprehensive patient and provider support services. Sponsored by: Thermo Fisher Scientific See how integration of innovative genetic analysis techniques into drug development is driving biopharma & biotech companies ahead. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Carla Vozone discusses the significant trends in the OINDP segment including large molecules and novel indications, changes within CDMOs and various challenges facing the industry. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. |
